共 50 条
- [21] INFLUENCE OF DOSE TITRATION OF CONCOMITANT STEROID AND METHOTREXATE DURING BIOLOGIC THERAPY ON REMISSION RATES IN PATIENTS WITH RHEUMATOID ARTHRITIS ACCORDING TO THE NEW ACR/EULAR REMISSION CRITERIA IN DAILY PRACTICE BASED ON THE IORRA COHORT ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 342 - 342
- [22] Patients with Rheumatoid Arthritis Who Are in Remission According to the New ACR/EULAR Criteria Have a Very High Functional Capacity Which Is Comparable to Healthy Subjects. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S53 - S54
- [28] Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE) ARTHRITIS RESEARCH & THERAPY, 2015, 17
- [29] Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE) Arthritis Research & Therapy, 17